We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Offers Draft Guidance for Developing Abuse-Deterrent Opioids
FDA Offers Draft Guidance for Developing Abuse-Deterrent Opioids
January 9, 2013
Drug manufacturers developing opioids with abuse-deterrent properties should use three categories of premarket studies to provide enough data on a drug’s prospects for reducing abuse or misuse, according to new draft FDA guidance.